Jim Simons Finch Therapeutics Group, Inc. Transaction History

Renaissance Technologies LLC

  • $63.1 Billion
  • Q3 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$0.34 - $0.56 $10,166 - $16,744
-29,900 Reduced 24.33%
93,000 $37,000
Q4 2022

Feb 13, 2023
BUY
$0.36 - $56.4 $29,628 - $4.64 Million
82,300 Added 202.71%
122,900 $59,000
Q3 2022

Nov 14, 2022
BUY
$1.75 - $51.3 $3,325 - $97,470
1,900 Added 4.91%
40,600 $68,000
Q2 2022

Aug 12, 2022
SELL
$1.91 - $5.11 $12,033 - $32,193
-6,300 Reduced 14.0%
38,700 $110,000
Q1 2022

May 13, 2022
BUY
$5.02 - $10.47 $36,716 - $76,577
7,314 Added 19.41%
45,000 $226,000
Q4 2021

Feb 11, 2022
BUY
$8.95 - $16.88 $337,289 - $636,139
37,686 New
37,686 $376,000

About Finch Therapeutics Group, Inc.

FNCH Quotes by TradingView
  • Ticker FNCH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,688,400
  • Market Cap $575M
  • Description
  • Finch Therapeutics Group, Inc., a clinical-stage microbiome therapeutics company, develops a novel class of orally administered biological drugs in the United States. The company's lead candidate is CP101, an orally administered microbiome capsule that is in Phase 3 clinical trial for the treatment of patients with recurrent Clostridioides diffi...
More about FNCH
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email